Continuum Advisory »

Rigel Pharmaceuticals shares owned by Continuum Advisory

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Continuum Advisory from 13F filings

Historical chart of Continuum Advisory investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Continuum Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Continuum Advisory

Quarter filed Position value Share count Share price at filing
2024-03-31 $595 584 1.02

More positions owned by Continuum Advisory

Capital Group Dividend Value Etf Etf (CGDV)
Apple Stock (AAPL)
Jpmorgan Core Plus Bond Etf Jpmorgan Core Plus Bond Fund Etf (JCPB)
Microsoft Corp Stock (MSFT)
Vanguard Extended Market Etf Etf (VXF)
Vanguard Total Stock Market Etf Etf (VTI)
Ishares 20 Year Treasury Bond Etf Etf (TLT)
Invesco Qqq Trust Series I Etf (QQQ)
Amazon Stock (AMZN)
Vanguard Total Bond Market Etf Etf (BND)
Barnes Group Stock (B)
Spdr Msci Usa Strategicfactors Etf Etf (QUS)
Vanguard Large-cap Etf Etf (VV)
Ishares S&p 100 Etf Etf (OEF)
Ishares Core S&p 500 Etf Etf (IVV)

View all positions for Continuum Advisory

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Vanguard Group
Soleus Capital Management
Acadian Asset Management
Geode Capital Management
State Street Corporation
Nuveen Asset Management
Jacobs Levy Equity Management
Renaissance Technologies
CM Management
Assenagon Asset Management
Millennium Management
Ing Investment Management

View all funds holding Rigel Pharmaceuticals